Finland Biotechnology & Medical Research

Faron Pharmaceuticals Oy (FARN)

Track

Faron Pharmaceuticals Oy recorded no insider trading activity within the last ninety days. The most recent transactions occurred on March 1, 2026, when key executives acquired shares. Prior to this, significant buying interest was observed in April 2024. These historical patterns reflect periodic capital commitments by leadership.

No active insider signal

Not featured in screeners

Featured in screeners

No active insider signal

Not featured in screeners

Ticker: FARN Exchange: LSE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

5 activity signals detected for Faron Pharmaceuticals Oy

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Faron Pharmaceuticals Oy. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Buy 1 Mar 2026

Value €1,156,482.83 | Price 13.79 | Shares 59,740

Buy 1 Mar 2026

Value €1,791,182.05 | Price 265.53 | Shares 87,167

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

Sale 12 Oct 2023

Value €19,129.50 | Price 3.83 | Shares 5,000

Sale 3 Oct 2023

Value €18,604.50 | Price 3.72 | Shares 5,000

Buy 5 Apr 2022

Value €70,532.50 | Price 2.82 | Shares 25,000

Buy 8 Jul 2020

Value £15,444.00 | Price 3.51 | Shares 4,400

Buy 12 May 2020

Value €15,139.30 | Price 4.33 | Shares 3,500

Buy 26 Oct 2018

Value £16,580.00 | Price 0.83 | Shares 20,000

Buy 17 Sep 2018

Value £4,414.00 | Price 1.00 | Shares 4,414

Buy 21 Jun 2018

Value £8,520.00 | Price 0.71 | Shares 12,000

Buy 21 Jun 2018

Value £17,040.00 | Price 0.71 | Shares 24,000

Buy 21 Jun 2018

Value £8,520.00 | Price 0.71 | Shares 12,000

Buy 21 Jun 2018

Value £17,670.00 | Price 0.57 | Shares 31,000

Buy 21 Jun 2018

Value £8,400.00 | Price 0.56 | Shares 15,000

Through Matti Karvonen, a closely affiliated person

Buy 21 Jun 2018

Value £1,125.00 | Price 0.75 | Shares 1,500

Buy 21 Jun 2018

Value £3,484.00 | Price 0.67 | Shares 5,200

Buy 21 Jun 2018

Value £4,424.00 | Price 0.56 | Shares 7,900

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-03-31	2026-03-01	B Purchase	Tuomo Pätsi Non-Executive Chairman Director	59,740 13.79 €1,156,483	59,740	13.79	€1,156,483
2026-03-25	2026-03-01	B Purchase	Sirpa Jalkanen PCA	87,167 265.53 €1,791,182	87,167	265.53	€1,791,182
2024-04-04	2024-04-03	B Purchase	Tuomo Pätsi Director Executive Director	12,958 258.14 €3,795,489	12,958	258.14	€3,795,489
2024-04-04	2024-04-03	B Purchase	Sirpa Jalkanen Director Executive Director	79,999 1.50 €119,998	79,999	1.50	€119,998
2024-04-04	2024-04-03	B Purchase	2.2 Markku Jalkanen Director Executive Director	79,999 1.50 €119,998	79,999	1.50	€119,998
2023-10-27	2023-10-12	S Sale	John Poulos Non-executive Director Executive Director	5,000 3.83 €19,130	5,000	3.83	€19,130
2023-10-27	2023-10-03	S Sale	John Poulos Non-executive Director Executive Director	5,000 3.72 €18,604	5,000	3.72	€18,604
2022-04-08	2022-04-05	B Purchase	2.2 Markku Jalkanen Chief Executive Officer Officer	25,000 2.82 €70,532	25,000	2.82	€70,532
2020-07-08	2020-07-08	B Purchase	2.4 Toni HÄonninen Chief Financial Officer Officer	4,400 3.51 £15,444	4,400	3.51	£15,444
2020-05-12	2020-05-12	B Purchase	2.4 Toni HÄonninen Chief Financial Officer Officer	3,500 4.33 €15,139	3,500	4.33	€15,139
2018-11-06	2018-10-26	B Purchase	1.0 Matti Karvonen VP Drug Development, Chief Medical Officer Officer	20,000 0.83 £16,580	20,000	0.83	£16,580
2018-09-18	2018-09-17	B Purchase	1.4 Minja Pfeiffer Chief Medical Officer Officer	4,414 1.00 £4,414	4,414	1.00	£4,414
2018-06-21	2018-06-21	B Purchase	3.2 Juho Jalkanen Chief Development Officer Officer	12,000 0.71 £8,520	12,000	0.71	£8,520
2018-06-21	2018-06-21	B Purchase	Mehto Saima Kuolinpesä Chief Development Officer Officer	24,000 0.71 £17,040	24,000	0.71	£17,040
2018-06-21	2018-06-21	B Purchase	2.2 Markku Jalkanen Chief Development Officer Officer	12,000 0.71 £8,520	12,000	0.71	£8,520
2018-06-21	2018-06-21	B Purchase	1.4 Minja Pfeiffer Chief Development Officer Officer	31,000 0.57 £17,670	31,000	0.57	£17,670
2018-06-21	2018-06-21	B Purchase	1.0 Matti Karvonen Chief Executive Officer Through Matti Karvonen, a closely affiliated person Officer	15,000 0.56 £8,400	15,000	0.56	£8,400
2018-06-21	2018-06-21	B Purchase	3.1 Pessi Honkasalo Medical Director Executive Director	1,500 0.75 £1,125	1,500	0.75	£1,125
2018-06-21	2018-06-21	B Purchase	3.3 Yrjö Wichmann Corporate Legal Counsel	5,200 0.67 £3,484	5,200	0.67	£3,484
2018-06-21	2018-06-21	B Purchase	Susanna Hedenström Chief Financial Officer Officer	7,900 0.56 £4,424	7,900	0.56	£4,424

Explore more

More insider trading research around Faron Pharmaceuticals Oy

More insider trades in Finland

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in Europe

Faron Pharmaceuticals Oy (FARN)

Track

Featured in screeners

Upgrade for signal details

Transactions

Insider

Sort by

Trades

Explore more